Up to 60% off Profit Pro - Limited Time Offer!
Winter Sale

60% off Profit Pro - Limited Time Offer!

As

Assertio Therapeutics Inc

ASRT · NASDAQ
ASRT · NASDAQ

Next Earnings: 10 Mar 2025

0.90
USD0.021.70%

Latest News

    @eWhispers
    eWhispers

    #earnings before the open tomorrow https://t.co/lObOE0dgsr $FSR $NKLA $NVAX $PLUG $DOCN $UAA $AMCX $EVGO $COTY $BLUE $DUK $J $SQSP $APD $FOXA $OTLY $GFS $ARMK $LEV $XXII $MRSN $ASC $NXST $WE $HR $IGT $CHH $CTLT $WRBY $CRON $TDG $VTNR $WHD $ESPR $SEAS $YOU $VYGR $ASRT $TH $WMG… https://t.co/TVmruTfhOC

    Analysts Recommendations

    Bullish

    Buy

    Strong Buy

    Buy

    Hold

    Sell

    Strong Sell

    Day Range

    0.86USD
    0.92USD

    52 Week Range

    0.73USD
    1.80USD

    Market Cap

    81.8MUSD

    About

    General Information

    Type

    Common Stock

    Exchange

    NASDAQ

    Currency Code

    USD

    Currency Name

    US Dollar

    Country Name

    USA

    Country ISO

    US

    ISIN

    US04546C2052

    CUSIP

    04545L107

    Sector

    Healthcare

    Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    December

    IPO date

    -

    Updated At

    -

    Highlights

    PE Ratio

    -

    PEG Ratio

    1.10

    Book Value

    1.38

    Dividend Share

    -

    Dividend Yield

    -

    Earnings Share

    -4.94

    Wall Street Target Price

    3.15

    EPS Estimate Current Year

    -0.18

    EPS Estimate Next Year

    -0.06

    EPS Estimate Current Quarter

    -0.03

    EPS Estimate Next Quarter

    -0.04

    Most Recent Quarter

    -

    Profitability

    Revenue TTM

    125,763,000

    Gross Profit TTM

    138,286,000

    EBITDA

    16,451,000

    Profit Margin

    -54.46%

    Return On Assets TTM

    -1.44%

    Return On Equity TTM

    -42.36%

    Revenue Per Share TTM

    1.322

    Qtly Revenue Growth YOY

    -18.00%

    Diluted Eps TTM

    -4.94

    Qtly Earnings Growth YOY

    -18.80%

    Valuation

    Trailing PE

    0.00

    Forward PE

    10

    Price Sales TTM

    0.6651

    Price Book MRQ

    0.6409

    Enterprise Value Revenue

    0

    Enterprise Value EBITDA

    4

    Peers analysis

    • Viatris Inc
      VTRSViatris Inc

      12.58

      1.04%
    • Teva Pharma Industries Ltd ADR
      TEVATeva Pharma Industries Ltd ADR

      22.64

      0.75%
    • Zoetis Inc
      ZTSZoetis Inc

      165.97

      0.60%
    • Haleon plc
      HLNHaleon plc

      9.74

      0.52%
    • MERCK Kommanditgesellschaft auf Aktien
      MKGAFMERCK Kommanditgesellschaft auf Aktien

      141.90

      0.45%
    • Merck KGaA ADR
      MKKGYMerck KGaA ADR

      28.82

      0.38%
    • Sa
      SDZXFSandoz Group AG

      41.19

      0.00%
    • Takeda Pharmaceutical Co. Ltd.
      TKPHFTakeda Pharmaceutical Co. Ltd.

      24.45

      0.00%
    • Teva Pharmaceutical Industries Limited
      TEVJFTeva Pharmaceutical Industries Limited

      18.50

      -8.82%
    • Takeda Pharmaceutical Co Ltd ADR
      TAKTakeda Pharmaceutical Co Ltd ADR

      13.14

      -0.23%